$HEPA NEWS!!!! Announces FDA Clearance of IND Application for CRV431 for COVID-19 - IND Expands Potential Indications for CRV431 Beyond NASH to Include COVID-19 - - CRV431 Poised to Move Directly into Phase 2 Clinical Study for COVID-19 - - Company May Seek Partnership (s) for COVID-